Hennion N, Bedart C, Vandomber L, Gottrand F, Humez S, Chenivesse C
Cell Mol Life Sci. 2025; 82(1):115.
PMID: 40074941
PMC: 11904048.
DOI: 10.1007/s00018-025-05620-0.
Klampfleitner S, Fertl A, Prinz O, Doerfler-Schalm M, Munker D, Henke M
Respir Med Case Rep. 2025; 54:102168.
PMID: 40007765
PMC: 11849196.
DOI: 10.1016/j.rmcr.2025.102168.
Brambilla M, Fumoso F, Conti M, Becchetti A, Bozzi S, Mencarini T
JACC Basic Transl Sci. 2025; 10(1):20-39.
PMID: 39958473
PMC: 11830264.
DOI: 10.1016/j.jacbts.2024.09.007.
Abbad L, Esteve E, Chatziantoniou C
Nat Rev Nephrol. 2025; .
PMID: 39934355
DOI: 10.1038/s41581-025-00934-5.
Jiang Y, Cai R, Huang Y, Zhu L, Xiao L, Wang C
Cell Death Discov. 2024; 10(1):487.
PMID: 39632841
PMC: 11618518.
DOI: 10.1038/s41420-024-02247-1.
Unraveling the Immune Web: Advances in SMI Capsular Fibrosis from Molecular Insights to Preclinical Breakthroughs.
Schoberleitner I, Faserl K, Lackner M, Coraca-Huber D, Augustin A, Imsirovic A
Biomolecules. 2024; 14(11).
PMID: 39595609
PMC: 11592141.
DOI: 10.3390/biom14111433.
OPN-Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH-Associated Liver Fibrosis.
Wang S, Gao J, Yang M, Zhang G, Yin L, Tong X
Adv Sci (Weinh). 2024; 11(47):e2405678.
PMID: 39473081
PMC: 11653607.
DOI: 10.1002/advs.202405678.
Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model.
Goksu A, Dirol H, Kocanci F
Pharmacol Res Perspect. 2024; 12(5):e70018.
PMID: 39360479
PMC: 11447456.
DOI: 10.1002/prp2.70018.
in fibrosis treatment: a comprehensive review.
Liang Q, Liu X, Peng X, Luo T, Su Y, Xu X
Front Pharmacol. 2024; 15:1442181.
PMID: 39139645
PMC: 11319160.
DOI: 10.3389/fphar.2024.1442181.
The differences in cytokine signatures between severe fever with thrombocytopenia syndrome (SFTS) and hemorrhagic fever with renal syndrome (HFRS).
Liu Z, Xue X, Geng S, Jiang Z, Ge Z, Zhao C
J Virol. 2024; 98(7):e0078624.
PMID: 38916398
PMC: 11265425.
DOI: 10.1128/jvi.00786-24.
Preclinical targeting of liver fibrosis with a Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.
Muns J, Schooten E, van Dasselaar R, Noordman Y, Adamzek K, Eibergen A
Eur J Nucl Med Mol Imaging. 2024; 51(12):3545-3558.
PMID: 38888612
PMC: 11445362.
DOI: 10.1007/s00259-024-06785-9.
Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis.
Ishii D, Kawasaki T, Sato H, Tatsumi K, Imamoto T, Yoshioka K
Int J Mol Sci. 2024; 25(7).
PMID: 38612561
PMC: 11011476.
DOI: 10.3390/ijms25073750.
Quantitative proteomics reveals the protective effects of Yinchenzhufu decoction against cholestatic liver fibrosis in mice by inhibiting the PDGFRβ/PI3K/AKT pathway.
Meng Q, Zhu H, Li Y, Peng X, Wang T, Huang H
Front Pharmacol. 2024; 15:1341020.
PMID: 38469403
PMC: 10926276.
DOI: 10.3389/fphar.2024.1341020.
Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers.
Perez-Favila A, Garza-Veloz I, Hernandez-Marquez L, Gutierrez-Vela E, Flores-Morales V, Martinez-Fierro M
Int J Mol Sci. 2024; 25(3).
PMID: 38338840
PMC: 10855955.
DOI: 10.3390/ijms25031562.
Schwann cell derived pleiotrophin stimulates fibroblast for proliferation and excessive collagen deposition in plexiform neurofibroma.
Tian Z, Du Z, Bai G, Gong Q, You Y, Xu G
Cancer Gene Ther. 2024; 31(4):627-640.
PMID: 38302728
DOI: 10.1038/s41417-024-00727-1.
Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials.
Di X, Chen J, Li Y, Wang M, Wei J, Li T
Clin Transl Med. 2024; 14(1):e1545.
PMID: 38264932
PMC: 10807359.
DOI: 10.1002/ctm2.1545.
Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells.
Kandhi R, Menendez A, Ramanathan S, Ilangumaran S
J Clin Exp Hepatol. 2023; 14(1):101280.
PMID: 38076369
PMC: 10709186.
DOI: 10.1016/j.jceh.2023.09.001.
Single-Cell Transcriptomics Reveals Pre-existing COVID-19 Vulnerability Factors in Lung Cancer Patients.
Liu W, Li W, Zhao Z
Mol Cancer Res. 2023; 22(3):240-253.
PMID: 38063850
PMC: 10922768.
DOI: 10.1158/1541-7786.MCR-23-0692.
Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis.
Chen D, Tzang C, Liu C, Chiu T, Lin J, Chuang P
Int J Mol Sci. 2023; 24(20).
PMID: 37894973
PMC: 10607574.
DOI: 10.3390/ijms242015294.
Tryptase-Positive Mast Cells Promote Adipose Fibrosis in Secondary Lymphedema through PDGF.
Nuri T, Jin D, Takai S, Ueda K
Curr Issues Mol Biol. 2023; 45(10):8027-8039.
PMID: 37886950
PMC: 10605118.
DOI: 10.3390/cimb45100507.